Parenteral nutrition for preterm infants: correcting for arachidonic and docosahexaenoic acid may not suffice.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

1. Nutritional interventions to prevent retinopathy of prematurity.Pediatric research · 2024
   Review
2. Modification of erythrocyte membrane phospholipid composition in preterm newborns with retinopathy of prematurity: The omegaROP study.Frontiers in cell and developmental biology · 2022
   Article

Corrections and comments

• Commented on by
  Reply to 'Parenteral nutrition for preterm infants: correcting for arachidonic and docosahexaenoic acid may not suffice'.2021
• Comment on
  Parenteral lipid emulsions in the preterm infant: current issues and controversies.2021

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as